We are live on ! Find out more
SGA

Sector Gamma AS Portfolio holdings

AUM $423M
1-Year Est. Return 17.56%
This Fund
S&P 500
This Quarter Est. Return
-6.26%
1 Year Est. Return
+17.56%
3 Year Est. Return
+28.73%
5 Year Est. Return
+52.48%
10 Year Est. Return
+238.19%
AUM
$486M
AUM Growth
+$96.7M
Cap. Flow
+$111M
Cap. Flow %
22.9%
Top 10 Hldgs %
62.84%
Holding
28
New
4
Increased
17
Reduced
4
Closed
3

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$27.6M
2
SHPG
Shire pic
SHPG
+$22.7M
3
MRK icon
Merck
MRK
+$22.3M
4
STJ
St Jude Medical
STJ
+$19.6M
5
PDCO
Patterson Companies, Inc.
PDCO
+$14.3M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$31.1M
2
BXLT
BAXALTA INC COM STK (DE)
BXLT
+$22.1M
3
CAH icon
Cardinal Health
CAH
+$10.1M
4
CYH icon
Community Health Systems
CYH
+$4.88M
5
ACH
Accendra Health
ACH
+$4.21M

Sector Composition

Rank Sector Weight
1 Healthcare 91.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LLY icon
1
Eli Lilly
LLY
$1.05T
$55.5M 11.43%
771,390
+365,000
+90% +$27.6M
BAX icon
2
Baxter International
BAX
$11.7B
$50M 10.3%
1,217,830
+280,230
+30% +$10.7M
BSX icon
3
Boston Scientific
BSX
$65.4B
$33.2M 6.84%
1,766,250
+362,890
+26% +$6.37M
IRWD icon
4
Ironwood Pharmaceuticals
IRWD
$635M
$27.2M 5.6%
2,969,188
+611,729
+26% +$5.05M
STJ
5
DELISTED
St Jude Medical
STJ
$26M 5.36%
473,514
+358,944
+313% +$19.6M
RVTY icon
6
Revvity
RVTY
$12.3B
$24.7M 5.08%
499,030
+92,400
+23% +$4.41M
SHPG
7
DELISTED
Shire pic
SHPG
$23.3M 4.8%
+135,680
New +$22.7M
MRK icon
8
Merck
MRK
$315B
$23M 4.73%
+455,000
New +$22.3M
BIIB icon
9
Biogen
BIIB
$30.4B
$21.3M 4.39%
81,910
+6,610
+9% +$1.75M
BMY icon
10
Bristol-Myers Squibb
BMY
$124B
$21M 4.32%
328,740
+116,250
+55% +$7.33M
IART icon
11
Integra LifeSciences
IART
$1.5B
$20.3M 4.18%
602,914
+108,048
+22% +$3.37M
BIO icon
12
Bio-Rad Laboratories Class A
BIO
$8.15B
$18.2M 3.74%
132,764
+12,934
+11% +$1.7M
MDVN
13
DELISTED
MEDIVATION, INC.
MDVN
$17.7M 3.65%
385,923
+219,570
+132% +$7.96M
VRTX icon
14
Vertex Pharmaceuticals
VRTX
$123B
$16.6M 3.41%
208,243
+91,610
+79% +$8.29M
PDCO
15
DELISTED
Patterson Companies, Inc.
PDCO
$15.4M 3.17%
+331,264
New +$14.3M
BXLT
16
DELISTED
BAXALTA INC COM STK (DE)
BXLT
$14.4M 2.96%
356,310
-559,690
-61% -$22.1M
MCK icon
17
McKesson
MCK
$98.5B
$13.9M 2.87%
88,640
+56,340
+174% +$9.1M
CI icon
18
Cigna
CI
$74.5B
$13.7M 2.81%
99,610
+9,590
+11% +$1.32M
MASI
19
DELISTED
Masimo
MASI
$13.3M 2.74%
318,463
+30,600
+11% +$1.15M
ACH
20
Accendra Health
ACH
$266M
$8.94M 1.84%
221,252
-113,050
-34% -$4.21M
WCG
21
DELISTED
Wellcare Health Plans, Inc.
WCG
$8.54M 1.76%
92,115
-7,750
-8% -$643K
MNTA
22
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$7.21M 1.48%
780,313
+355,777
+84% +$3.83M
UTHR icon
23
United Therapeutics
UTHR
$22.7B
$6.71M 1.38%
+60,204
New +$7.62M
THC icon
24
Tenet Healthcare
THC
$16.8B
$5.16M 1.06%
178,490
-79,600
-31% -$2.07M
SPPI
25
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$506K 0.1%
79,600
+3,600
+5% +$18.5K
1
2

Similar funds

AFWM
AMJ Financial Wealth Management Leesburg, Virginia $424M AUM 37.24% 1-Year Est. Return
MP
McDonald Partners Cleveland, Ohio $424M AUM 29.07% 1-Year Est. Return
DS
Dalal Street West Lake Hills, Texas $423M AUM 115.19% 1-Year Est. Return
RS
Retirement Solution Redmond, Washington $423M AUM 16.83% 1-Year Est. Return
DF
Dunhill Financial London, United Kingdom $424M AUM 16.79% 1-Year Est. Return
OGM
OnyxPoint Global Management New York $424M AUM 84.95% 1-Year Est. Return
CPIM
Cypress Point Investment Management Mill Valley, California $424M AUM
MPPLM
Midwest Professional Planners Ltd (MPPL) Wausau, Wisconsin $425M AUM 28.89% 1-Year Est. Return

Sector Gamma AS's Q1 2016 Portfolio in Review

As of Q1 2016, Sector Gamma AS held 28 positions worth $486M, up 25% from $389M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Sector Gamma AS deployed $111M of net new capital in Q1 2016, opening 4 new positions and adding to 17 existing holdings. Its largest new stake was Shire pic: 135,680 shares worth $23.3M.

By sector, the portfolio is most concentrated in Healthcare at 92% of assets, up from 87% a quarter earlier.

On the sell side, the largest reduction was BAXALTA INC COM STK (DE), an estimated $22.1M trimmed.

  • Sector Gamma AS's largest Q1 2016 buy was Shire pic: 135,680 shares worth $23.3M.
  • Sector Gamma AS added most to Eli Lilly in Q1 2016, an estimated $27.6M increase.
  • Sector Gamma AS's biggest Q1 2016 reduction was BAXALTA INC COM STK (DE), cutting an estimated $22.1M.
  • Sector Gamma AS fully exited Johnson & Johnson in Q1 2016, selling an estimated $31.1M.
  • Sector Gamma AS's ten largest holdings make up 63% of its $486M portfolio in Q1 2016.
  • Sector Gamma AS opened 4 new positions and closed 3 in Q1 2016.
  • Sector Gamma AS's portfolio value rose 25% quarter-over-quarter to $486M.

Based on Sector Gamma AS's 13F filing for Q1 2016, filed 27 May 2016.